The First Man CURED of Type 1 Diabetes | VX-880

Описание к видео The First Man CURED of Type 1 Diabetes | VX-880

In my previous video (   • Can Vertex Pharmaceuticals and Dougla...  ), I talked about a potential cure for type 1 diabetes with the ongoing phase ½ clinical trial of VX-880 from Vertex Pharmaceuticals (VRTX). In this video, we are going to hear about the story of the first trial participant, Brian Shelton, who says he feels cured after living with diabetes for almost 50 years. Type 1 diabetes is a chronic disease in which the insulin-making cells in the pancreas are destroyed, forcing a person to be dependent on insulin -- delivered via shots or an insulin pump -- to stay alive.

Scientific background on VX-880 and type 1 diabetes:
Can Vertex Pharmaceuticals and Douglas Melton CURE Type 1 Diabetes?
   • Can Vertex Pharmaceuticals and Dougla...  

My Favorite Books on Biotech and Investing
The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race
https://amzn.to/3rgGAve

#Diabetes
#VRTX
#VX880
#BrianShelton
#Vertex
#Semma
#DouglasMelton
#StemCell
#Type1Diabetes
#CellTherapy
#CathyWood
#ARKG
#Stock
#BiotechInvestor

0:00 Introduction
0:55 Brian Shelton: The first man cured of Type 1 Diabetes
2:30 Douglas Melton and VX-880
4:26 Brian Shelton Interview
7:42 Clinical Trial of VX-880
8:08 Hope For The Future

References
Man says he feels cured after living with diabetes for almost 50 years
https://www.goodmorningamerica.com/we...

A Cure for Type 1 Diabetes? For One Man, It Seems to Have Worked.
https://www.nytimes.com/2021/11/27/he...

A Safety, Tolerability, and Efficacy Study of VX-880 in Participants With Type 1 Diabetes
https://clinicaltrials.gov/ct2/show/N...

Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880
https://news.vrtx.com/press-release/v...


***Disclaimer
I (Biotech Investor) hold a Ph.D. degree in life science and conducted 5 years of postdoctoral training in molecular biophysics at UC Berkeley. I am currently a full-time employee of a clinical-stage biopharmaceutical company, conducting early-stage drug discovery research. I have no professional affiliation with any of the companies or stocks discussed on this channel. This video is strictly for educational and entertainment purposes, and none of the contents in the video are for medical or financial/investment advice. I have no obligation to update, change or correct any information described in this video as news and stock prices change. The thoughts described in this channel are my own and do not reflect the company that I work for. This is not a solicitation to invest in any company I discussed in this channel, and I am not a financial or medical advisor. Investment involves risks and past performance should not be used as a gauge for future success. Seek a financial advisor to determine the appropriate investment strategies for your given circumstances. Investors should obtain their own independent financial advice and understand the risks associated with investment products/ services before making investment decisions.

Комментарии

Информация по комментариям в разработке